Very long acting (> 6–8 h) levodopa preparations are still likely to represent the next chapter in the medical treatment of PD. Continuous-infusion levodopa gel, long-acting levodopa pills, ...
Whether levodopa is detrimental, beneficial, or without effect on the rate of the progression of Parkinson's disease is unknown and extremely important, both scientifically and clinically. We ...
In biotech, the most compelling investment stories often emerge where medical need, scientific differentiation, and timing ...
A once-a-week Parkinson’s injection could replace multiple daily pills, thanks to a new slow-release formulation developed by researchers. It promises easier treatment, fewer missed doses, and better ...
Despite being a mainstay of Parkinson's disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side-effects with long-term use. A recent human trial found that a new drug ...
Levodopa is in a class of medications called central nervous system agents which are converted to dopamine in the brain. Carbidopa is in a class of medications called decarboxylase inhibitors which ...
We present the case of a male in his mid-30s with a progressive complex neurological phenotype primarily characterised by levodopa-responsive parkinsonism with motor fluctuations as well as gait ...
Scientists have found a key brain network that’s disrupted by Parkinson’s disease, according to a study published today in ...
That may be because the disease disrupts communication in a brain network that links the body and mind, a team reports in the journal Nature. “It almost feels like a tunnel is j ...
The cardinal motor features of PD are bradykinesia, rigidity and resting tremor. The disease is typically asymmetric, starting on one side and remaining worse on that side as the disease progresses.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results